ASIT Biotech S.A. announced that during the board of directors' meeting of January 16, 2020, Harry Welten and Jean-Paul Prieels informed the board of directors of their intention to resign as directors at the next general meeting of the company. Mr. Louis Champion, permanent representative of ZOPAMAVI SAS, also submitted his resignation with immediate effect. Mr. Yves Désiront, permanent representative of RE FINANCE CONSULTING SA was appointed Chairman of the board of directors in place of Mr. Louis Champion, permanent representative of ZOPAMAVI SAS.